Contractor
TEVA PHARMACEUTICALS USA, INC.
- UEI
- NEN9A34LRHJ5
- Parent UEI
- NEN9A34LRHJ5
- Resolved by
- uei
- Confidence
- 1.000
Active from Mar 18, 2026 to Jul 23, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36E79722D0021 EXERCISE 4TH OPTION YEAR WITH NO PRICE CHANGES | Department of Veterans Affairs | — | Jun 3, 2026 | — |
| 36F79726D0125 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | May 28, 2026 | — |
| 36E79723D0023 EXERCISE THE 3RD YEAR FOR GLATIRAMER ACETATE INJECTIONS CONTRACT 36E79723D0023 WITH TEVA PHARMACEUTICALS USA, INC. WITH A PERIOD OF PERFORMANCE OF AUGUST 5, 2026 TO AUGUST 4, 2027 WITH NO PRICE CHANGES | Department of Veterans Affairs | — | Jul 7, 2026 | — |
| V797D70217 65IB / (42-2A) / PRODUCT DELETION | Department of Veterans Affairs | — | Apr 10, 2026 | — |
| SPE2DP26F4635 8512042003!ADENOVIRUS TYPE 4 A | Department of Defense | NJ | Apr 15, 2026 | $343,526 |
| SPE2DP26F4634 8512042000!ADENOVIRUS TYPE 4 A | Department of Defense | NJ | Apr 15, 2026 | $343,526 |
| SPE2DP26F4637 8512042008!ADENOVIRUS TYPE 4 A | Department of Defense | NJ | Apr 15, 2026 | $515,290 |
| SPE2DP26F4633 8512041924!ADENOVIRUS TYPE 4 A | Department of Defense | NJ | Apr 15, 2026 | $1,030,579 |
| SPE2DP26F4638 8512042009!ADENOVIRUS TYPE 4 A | Department of Defense | NJ | Apr 15, 2026 | $343,526 |
| SPE2DP26F4639 8512042110!ADENOVIRUS TYPE 4 A | Department of Defense | NJ | Apr 15, 2026 | $515,290 |
| SPE2DP26F4632 8512041922!ADENOVIRUS TYPE 4 A | Department of Defense | NJ | Apr 15, 2026 | $171,763 |
| SPE2DP26F4636 8512042006!ADENOVIRUS TYPE 4 A | Department of Defense | NJ | Apr 15, 2026 | $687,053 |
| SPE2DP26F3587 8511984336!ADENOVIRUS TYPE 4 A | Department of Defense | NJ | Mar 18, 2026 | $343,526 |
| SPE2DP26F3586 8511984334!ADENOVIRUS TYPE 4 A | Department of Defense | NJ | Mar 18, 2026 | $3,950,554 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier NEN9A34LRHJ5, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.